Prevention    Evidence-based guidelines for cardiovascular disease prevention in women J Am Coll Cardiol (2004);43:900-21 L. Mosca, et al. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease Eur Heart J (2004);25:484-91 J. Emberson, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial Jama (2004);292:1307-16 J. A. de Lemos, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet (2004);364:685-96 H. M. Colhoun, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med (2004);350:1495-504 C. P. Cannon, et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis Circulation (2004);109:1536-42 R. Candido, et al. Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention Am J Cardiol (2004);93:1030-2 R. L. Bard, et al.